Skip to main content
Caplight Logo









OneOme

OneOme

Private
Minneapolis, MinnesotaHealthcare & Life Scienceshttps://oneome.com/

Last Round

VC Round

Oct 15, 2016

Company Overview

OneOme is a biotechnology company that provides a pharmacogenomic and analytical platform designed to help doctors select medications to improve outcomes and reduce adverse drug reactions.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Healthcare Analytics, EHR & EMR

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

pharmacogenomic testingPGx testingprecision medicinepersonalized medicationclinical decision supportdrug response predictiongenetic testingdrug-gene testingEHR integrationoncology pharmacogenomicsadverse drug reaction preventiongene panel testingCLIA certified labpopulation health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OneOme Comparables

Compare OneOme with similar companies based on industry and business-model similarity.

OneOme comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ActX, Inc.
86%
Admera Health
83%
Genomind
80%

OneOme Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 15, 2016
SeedSep 23, 2014

OneOme Investors

Notable investors and investment history

OneOme investors
InvestorRounds
InvenshureVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors increased 50% MoM.

  • Apr 14, 2025

    Monthly visitors grew 216% MoM, reaching 11.7K.

OneOme Filings

Explore SEC and related filing metadata, where available.

OneOme filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OneOme's valuation, stock price, and market status.

Is OneOme a public or private company?

OneOme is a private company.

What is the current stock price of OneOme?

OneOme is a private company with no public stock price. No recent secondary market data is available.

How much is OneOme worth (valuation)?

Valuation information for OneOme is not publicly available.

Can I buy OneOme stock?

OneOme shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OneOme's last funding round?

OneOme's most recent funding round was VC Round on October 15, 2016.

Who are the main investors in OneOme?

Key investors in OneOme include Invenshure.

Will OneOme IPO soon?

No public IPO plans have been announced for OneOme.

How can I track OneOme secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OneOme's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMinneapolis, Minnesota
Employee Range13
Year Founded2013
Last FundingOct 15, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?